|
FAU expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.955200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.966000E-01 |
| Normal-vs-Stage2 |
6.838600E-01 |
| Normal-vs-Stage3 |
8.930400E-01 |
| Normal-vs-Stage4 |
8.182600E-01 |
| Stage1-vs-Stage2 |
5.734600E-01 |
| Stage1-vs-Stage3 |
9.659600E-01 |
| Stage1-vs-Stage4 |
6.763200E-01 |
| Stage2-vs-Stage3 |
5.742400E-01 |
| Stage2-vs-Stage4 |
8.428800E-01 |
| Stage3-vs-Stage4 |
7.165000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.409600E-01 |
| Normal-vs-AfricanAmerican |
2.508800E-01 |
| Normal-vs-Asian |
6.295600E-01 |
| Caucasian-vs-AfricanAmerican |
2.139400E-01 |
| Caucasian-vs-Asian |
6.015600E-01 |
| AfricanAmerican-vs-Asian |
1.613760E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.286000E-01 |
| Normal-vs-Female |
9.790800E-01 |
| Male-vs-Female |
8.681800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.626800E-01 |
| Normal-vs-Age(41-60Yrs) |
9.267600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.558600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.001600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.215800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.191170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.819000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.050000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.178000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.130400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.640400E-01 |
| Classical-VS-Follicular |
2.226000E-01 |
| Classical-VS-Other |
2.585800E-01 |
| Classical-VS-Normal |
7.195000E-01 |
| Tall-VS-Follicular |
3.391000E-01 |
| Tall-VS-Other |
1.404210E-01 |
| Tall-VS-Normal |
8.027200E-01 |
| Follicular-VS-Other |
3.840400E-01 |
| Follicular-VS-Normal |
4.891000E-01 |
| Other-VS-Normal |
2.983000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.326000E-01 |
| Normal-vs-N1 |
4.790200E-01 |
| N0-vs-N1 |
7.012400E-01 |
|
|
